Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Crisis Response Plan: Hepatotoxicity Signal Framing note up front: I'm treating this as a US/FDA-regulated situation. Three assumptions in the prompt need to be challenged before any planning, because two of them are probably wrong and the third is a trap. The Three Reframes That Drive Everything 1.Read the full answer
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer